Showing 11-20 of 197 results for "".
First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20813/Subcision Plus Sublative Technologies to Treat Acne Scars
https://practicaldermatology.com/topics/general-topics/subcision-plus-sublative-technologies-to-treat-acne-scars/20462/Combining something old and something new to create something skintastic.What Does Dermatology Need Right Now?
https://practicaldermatology.com/topics/practice-management/what-does-dermatology-need-right-now/23061/Experts weigh in on the pressing needs of the specialty today.A Closer Look at Sunscreens: Insights, Innovations, and Inaccuracies
https://practicaldermatology.com/topics/skin-cancer-photoprotection/a-closer-look-at-sunscreens-insights-innovations-and-inaccuracies/20504/Experts weigh in on the current state of SPF and skin protection.The Current Armamentarium of Topical Therapies to Treat Atopic Dermatitis and Psoriasis
https://practicaldermatology.com/topics/atopic-dermatitis/the-current-armamentarium-of-topical-therapies-to-treat-atopic-dermatitis-and-psoriasis/23748/A review of the alternatives to topical corticosteroids for managing common inflammatory skin diseases.- Johnson & Johnson Consumer to Acquire NeoStratahttps://practicaldermatology.com/news/johnson-johnson-consumer-to-to-acquire-neostrata/2458589/Johnson & Johnson Consumer, Inc. has entered into a definitive agreement to acquire NeoStrata Company, Inc. The acquisition will include NeoStrata's affiliates and parent company TriStrata, Incorporated, a privately-held compan
- EpigenCare Named as Johnson & Johnson Innovation Finalist in Skincare Challengehttps://practicaldermatology.com/news/epigencare-named-as-johnson-johnson-innovation-finalist-in-skincare-challenge/2457829/EpigenCare Inc., a personalized skincare startup company, is a finalist in Johnson & Johnson Innovation’s Digital Beauty Quickfire Challenge. The Challenge
- Johnson & Johnson Completes Acquisition of Yellow Jersey Therapeuticshttps://practicaldermatology.com/news/Johnson-johnson-completes-acquisition-yellow-jersey-therapeutics/2467362/Johnson & Johnson has successfully completed the acquisition of Yellow Jersey, a demerged subsidiary of Numab Therapeutics, to secure the global rights to NM26, a novel, investigational first-in-class bispecific antibody being evaluated for the treatment of atopic dermatitis
- Johnson & Johnson Announces Kenvue as the Name for New Consumer Health Companyhttps://practicaldermatology.com/news/johnson-johnson-announces-kenvue-as-the-name-for-new-consumer-health-company/2461363/Johnson & Johnson’s planned new consumer health company will be named...Kenvue. Kenvue (pronounced ken·view), is inspired by two powerful ideas: “ken” – meaning knowledge, an English word primarily used in Scotland, and “vue,” ref